# US 2019/0376047 A1 · Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376047 A1
- Document ID: US20190376047A1
- Status: Published application
- Kind: A1
- Application number: 16/484,167
- Filed: 2018-02-08
- Published: 2019-12-12
- Earliest claimed: 2017-02-08
- Assignees: Orig3n, Inc.
- Applicants: Orig3n, Inc.
- Inventors: Robin Y. Smith; Marcie A. Glicksman
- Web page: https://patentgrep.com/patent/US20190376047A1

## CPC

- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- G01N 33/56966: {Animal cells}
- G16B 35/10: Design of libraries
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2510/00: Genetically modified cells
- C12N 2510/02: Cells for production
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Described herein are various systems, methods, and apparatus for systematic creation of isolated homogeneous colonies of cells from vector-based lineages. The vector-based lineages may originate from multiple types of viral vector families (e.g., Paramyx-oviridae, Retroviridae, Parvoviridae) or non-natural engineered vectors or a plurality of vector combinations, for example. In certain embodiments, the isolated homogeneous colonies of cells are vector-free sub-colonies; in other embodiments, the isolated homogeneous colonies of cells are homogeneous vector sub-colonies. In other embodiments, vector mixed sub-colonies are created. The disclosed systems, methods, and apparatus are useful for inducible pluripotent stem cell (iPSC) production and work by selectively binding to one or more corresponding protein markers expressed on the surface of a cell that indicate that cellular reprogramming has occurred. Software is used to automate the purification and isolation of the iPSCs produced.

## Claims

### Claim 1

A method for isolating and producing induced pluripotent stem cells (iPSCs), the method comprising:
providing a colony of cells having been contacted with one or more vectors;
detecting a plurality of cell surface markers expressed on the surface of the iPSCs, wherein each of the plurality of cell surface markers is indicative of a vector contacted with the colony of cells;
mapping, by a processor of a computer device, a plurality of candidate binding agents to the plurality of cell surface markers;
selecting at least one of the plurality of candidate binding agents for specific binding to at least one of the plurality of cell surface markers;
contacting the colony of cells with one or more of the selected binding agents; and
separating the iPSCs from the colony of cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the colony of cells comprises somatic cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein each vector of the one or more vectors comprises multiple vector families.

### Claim 4 (depends on 1)

The method of claim 1, wherein the plurality of candidate binding agents comprise one or more members selected from the group consisting of an antibody, a biotinylated bead, a hydrophobic bead, and a magnetic nanoparticle.

### Claim 5 (depends on 1)

The method of claim 1, wherein separating the iPSCs from the colony of cells comprises:
separating the iPSCs into vector-based lineages using one or more members selected from the group consisting of single bead separation, column chromatography, serial separation, microfluidic channel separation, magnetic bead binding, fluorescence activated cell (FACS) sorting, and antibody binding.

### Claim 6 (depends on 1)

The method of claim 1, the method comprising:
determining, by the processor, a prescribed order in which the selected binding agents are to be contacted with the colony of cells for desired specific binding.

### Claim 7

The method of any one of the preceding claims, the method comprising:
displaying or causing to be displayed on a graphical user interface (GUI) module, by the processor, a representation of one or more separation methodologies for separation of the iPSCs from the colony of cells using the selected binding agents.

### Claim 8

The method of any one of the preceding claims, comprising:
generating one or more isolated homogeneous colonies of iPSCs from a single vector lineage.

### Claim 9 (depends on 8)

The method of claim 8, wherein the one or more isolated homogeneous colonies of iPSCs comprise a genetic variant of the colony of cells.

### Claim 10 (depends on 8, 9)

The method of claim 8 or 9, wherein the one or more isolated homogeneous colonies of iPSCs are vector-free.

### Claim 11

The method of any one of the preceding claims, wherein the GUI module displays, in a first designated location of the GUI display, a list of, and/or icon(s) representing one or more electronic files corresponding to the plurality of cell surface markers and/or candidate binding agents.

### Claim 12 (depends on 11)

The method of claim 11, wherein each of the one or more electronic files contains a plurality of vectors in a second designated location of the GUI display.

### Claim 13 (depends on 11, 12)

The method of claim 11 or 12, wherein the GUI module displays, in a third designated location of the GUI display, a list of, and/or icon(s) representing the plurality of candidate binding agents mapped to the plurality of cell surface markers corresponding to the one or more electronic files listed and/or represented in the first designated location of the GUI display.

### Claim 14

A method for electronically determining and compiling a list of binding agents from a storage facility comprising one or more electronic files, the method comprising:
receiving, by a processor of a computer device, data from the detection of a plurality of cell surface markers expressed on the surface of iPSCs;
determining, by the processor, one or more vectors contacted to the colony of cells based on the detected cell surface markers;
mapping, by the processor, the determined one or more vectors to a list of a plurality of cell surface markers contained in the one or more files of the storage facility; and
mapping one or more binding agents contained in an electronic compendium having a binding specificity for each mapped cell surface marker.

### Claim 15 (depends on 14)

The method of claim 14, comprising:
displaying or causing to be displayed, by a processor of a computer device, in a first designated location of a graphical user interface module, a list of, and/or icon(s) representing, one or more electronic files corresponding to the one or more binding agents mapped to the plurality of cell surface markers.

### Claim 16

A method comprising:
providing a heterogeneous mixture of a plurality of colonies of cells having been contacted with a plurality of vectors;
producing a colony of iPSCs from the plurality of colonies of cells, wherein the colony of iPSCs comprises varied genetic edits; and
separating the colony of iPSCs into one or more homogeneous vector lineages.

### Claim 17 (depends on 16)

The method of claim 16, wherein the colonies of cells comprises somatic cells.

### Claim 18 (depends on 16)

The method of claim 16, wherein each vector of the plurality of vectors comprises multiple vector families.

### Claim 19 (depends on 16)

The method of claim 16, wherein separating the iPSCs into one or more homogeneous vector lineages comprises:
separating the iPSCs into cell surface marker-based lineages determined using one or more members selected from the group consisting of single bead separation, column chromatography, serial separation, microfluidic channel separation, magnetic bead binding, fluorescence activated cell (FACS) sorting, and antibody binding.

### Claim 20

The method of any one of the preceding claims, wherein the plurality of cell surface markers is produced by a type of vector family and/or vector.

### Claim 21 (depends on 20)

The method of claim 20, wherein the plurality of cell surface markers is produced by one or more members selected from the group consisting of Paramyxoviridae virus vector family, Retroviridae virus vector family, Parvoviridae virus vector family, and a non-natural engineering vector.

### Claim 22 (depends on 21)

The method of claim 21, wherein the plurality of cell surface markers is produced by Paramyxoviridae virus vector family and wherein the Paramyxoviridae virus vector family comprises one or more members selected from the group consisting of Atlantic salmon paramyxovirus, Newcastle disease virus, Mumps virus, Ferlavirus, Hendravirus, Nipahvirus, Measels, Sendai, Avian pneumovirus, Tioman virus, and TPMV-like virus.

### Claim 23 (depends on 22)

The method of claim 22, wherein the plurality of cell surface markers comprise one or more members selected from the group consisting of Nucleocapsid protein (NP), Phosphoprotein (P), Matrix protein (M), Fusion protein (F), and Hemagglutinin-Neuraminidase (HN), Large protein (L).

### Claim 24 (depends on 21)

The method of claim 21, wherein the plurality of cell surface markers is produced by Retroviridae virus vector family and wherein the Retroviridae virus vector family comprises one or more members selected from the group consisting of Avian leukosis virus, Mouse mammary tumor virus, Murine leukemia virus, Feline leukemia virus, Bovine leukemia virus, Human T-lymphotropic virus, and lentivirus.

### Claim 25 (depends on 24)

The method of claim 24, wherein the plurality of cell surface markers is produced by lentivirus, and wherein the lentivirus is or comprises the Human immunodeficiency virus 1.

### Claim 26 (depends on 24)

The method of claim 24, wherein the plurality of cell surface markers comprise one or more members selected from the group consisting of Capsid, Reverse Transcriptase, Integrase, Protease, p6, p7, p17, p24, gp41, and gp120.

### Claim 27 (depends on 21)

The method of claim 21, wherein the plurality of cell surface markers is produced by Parvoviridae virus vector family and wherein the Parvoviridae virus vector family comprises one or more members selected from the group consisting of Primate tetraparvovirus, Rodent protoparvovirus, Sesavirus, and Primate erythroparvovirus

### Claim 28 (depends on 27)

The method of claim 27, wherein the plurality of cell surface markers comprise one or more members selected from the group consisting of virion proteins, VP1, VP2, VP3, VP4, VPS, Capsid, phospholipase A2, non-structural proteins (NS), NS1, and NS2.

### Claim 29

A method comprising:
expanding a population of cells in a cell culture medium for greater than 15 days;
following the expanding step, isolating the population of cells that express a cell surface marker of interest; and
contacting a plurality of viral vectors with the enriched population of cells.

### Claim 30 (depends on 29)

The method of claim 29, comprising:
following the contacting step, selecting the enriched population of cells for a gene of interest.
